MedPath

A Study on the Epidemiology of Invasive Aspergillosis and Resistance Patterns of Aspergillus spp.

Recruiting
Conditions
B44
C91.0
C92.0
Aspergillosis
Acute lymphoblastic leukaemia [ALL]
Acute myeloblastic leukaemia [AML]
Registration Number
DRKS00003436
Lead Sponsor
Klinik I für Innere MedizinUniklinik KölnBettenhaus, Ebene 15, Raum 64
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

Patients with acute leukemia

Exclusion Criteria

Patients without acute leukemia

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival after 14, 28, 84 days
Secondary Outcome Measures
NameTimeMethod
- the development of resistance in Aspergillus spp. identified by microbiological analyses conducted after diagnosis of invasive aspergillosis<br>- efficacy of different therapies against invasive Aspergillosis provided after diagnosis of the disease
© Copyright 2025. All Rights Reserved by MedPath